Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of IL-40 and IL-41 Levels in Patients With Sepsis and Septic Shock to Healthy Individuals

NCT06963541 is registered in ClinicalTrials.gov with Melahat Yalcin Solak as lead sponsor.

NCT NCT06963541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06963541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of IL-40 and IL-41 Levels in Patients With Sepsis and Septic Shock to Healthy Individuals
Lead sponsor
Melahat Yalcin Solak
Phase
Observational
Overall status
Not yet recruiting
Start date
May 15, 2025
Completion date
December 31, 2025
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarkers, inflammation, sepsis, septic shock